Stock & Company Details
Design Therapeutics Inc $DSGN
Price:
N/A
N/A
63M
$954M
52 Week High:
N/A
10 Day Average Volume:
N/A
-12.80
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DSGN technical indicators
Latest Design Therapeutics Inc (DSGN) indicator readings as of 2026-08-28.
DSGN's 14-day RSI is 57.8, in neutral territory. At $15.11 it is trading 32.0% above its 200-day moving average of $11.45, and above its 50-day average of $13.89. Price sits in the middle of its Bollinger Bands ($13.00 to $16.38). ADX reads 27.7, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations.
Finance Bot
Ask your questions
Start by typing a question below.
